查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1589601

药物发现服务市场：按流程、药物类型、服务类型、治疗领域和最终用户划分 - 2025-2030 年全球预测

Drug Discovery Services Market by Process (Candidate Validation, Hit-to-Lead Identification, Lead Optimization), Drug Type (Biologics, Small Molecules), Service type, Therapeutic Area, End-user - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年药物发现服务市值为217.7亿美元，预计到2024年将达到247.9亿美元，复合年增长率为14.37%，到2030年将达到557.5亿美元。

药物发现服务市场在医疗保健领域至关重要，重点是在药物研发的各个阶段（从目标识别到先导药物最适化）提供全面支援。由于对创新治疗方法的需求不断增长以及对治疗慢性和危及生命的疾病的具有成本效益的解决方案的需求，这个市场变得至关重要。其应用范围涵盖製药公司、生物技术公司、大学和研究机构，最终用途范围从早期药物筛检到支援临床前和临床试验。高通量筛检、生物资讯学和机器学习等技术进步，以及快速增加的研发支出和药物发现外包推动了市场成长。机会在于扩大预测模型和个人化医疗的人工智慧集成，以及透过合作伙伴关係加强药物开发流程。为了抓住这些机会，企业应专注于培育与研究机构和高科技公司的策略联盟，并投资最尖端科技。然而，市场面临严格的监管要求、高昂的初始资本投资以及药物开发过程的复杂性等挑战。这些限制可能会阻碍快速成长。用于基因编辑的 CRISPR 技术、即时资料分析和改进的虚拟筛检方法等领域的创新为业务成长提供了可行的途径。随着市场性质的发展，我们看到了向更多协作计划和鼓励知识和资源共用的开放原始码平台的转变。因此，企业应该透过采用支援迭代学习和适应的灵活营运框架来提高创新能力。公司还必须保持敏捷性并回应监管变化和市场需求，才能在竞争格局中取得成功。透过专注于客户需求和技术集成，公司可以驾驭市场复杂性并推动永续成长。

主要市场统计
基准年[2023] 217.7亿美元
预测年份 [2024] 247.9亿美元
预测年份 [2030] 557.5亿美元
复合年增长率（%） 14.37%

市场动态：揭示快速发展的药物发现服务市场的关键市场洞察

供需的动态交互作用正在改变药物发现服务市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 扩大医药及生物製药产业研发投入
    • 对分析测试和临床试验服务外包的需求日益增长
    • 罕见疾病及孤儿药研究
  • 市场限制因素
    • 昂贵的药物发现和药物开发
  • 市场机会
    • 专注于生技药品开发和药物发现
    • 专利到期的可能性
  • 市场挑战
    • 关于药物发现和动物使用的严格政府法规

波特五力战略工具引领药物发现服务市场

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解药物发现服务市场的外部影响

外部宏观环境因素在塑造药物发现服务市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解药物发现服务市场的竞争状况

对药物发现服务市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来发现自己的竞争定位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵药物发现服务市场供应商绩效评估

FPNV定位矩阵是评估药物发现服务市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议绘製药物发现服务市场的成功之路

药物发现服务市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 加大医药及生物製药产业研发投入
      • 分析测试和临床试验服务外包需求成长强劲
      • 罕见疾病及罕见疾病药物研究
    • 抑制因素
      • 昂贵药物的发现与开发
    • 机会
      • 专注于生技药品开发和药物发现
      • 专利到期的可能性
    • 任务
      • 关于药物发现和动物使用的严格政府法规
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章药物发现服务市场：依流程

  • 候选人检验
  • 从命中到线索的识别
  • 先导药物最适化
  • 目标选择
  • 目标检验

第七章依药物类型分類的药物发现服务市场

  • 生物製药
  • 小分子

第八章药物发现服务市场：依服务类型

  • 生物服务
  • 化学服务

第九章依治疗领域分類的药物发现服务市场

  • 心血管疾病
  • 消化系统疾病
  • 神经病学
  • 肿瘤学

第10章药物发现服务市场：依最终用户分类

  • 学术机构
  • 製药和生物技术公司

第十一章 北美和南美药物发现服务市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十二章亚太药物发现服务市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十三章欧洲、中东和非洲的药物发现服务市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第14章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Aganitha AI Inc.
  • Agilent Technologies, Inc.
  • Aurigene Discovery Technologies
  • BellBrook Labs
  • BioAscent Discovery Ltd.
  • Charles River Laboratories International, Inc.
  • Domainex Ltd.
  • Enzo Life Sciences Inc.
  • Eurofins Scientific SE
  • Frontage Laboratories, Inc.
  • GenScript Biotech Corporation
  • Integrated DNA Technologies, Inc.
  • IQVIA Inc
  • Jubilant Biosys Ltd.
  • Labcorp Drug Development
  • Merck KGaA
  • Piramal Pharma Solutions
  • Proteros biostructures GmbH
  • Sai Life Sciences Limited
  • Schrodinger, Inc.
  • Selvita SA
  • Shanghai ChemPartner
  • Shanghai Medicilon, Inc.
  • Symeres
  • Syngene International Limited
  • TCG Lifesciences Pvt. Limited
  • Thermo Fisher Scientific Inc.
  • UCB SA
  • Viva Biotech
  • Wuxi Apptec
Product Code: MRR-6611A511167C

The Drug Discovery Services Market was valued at USD 21.77 billion in 2023, expected to reach USD 24.79 billion in 2024, and is projected to grow at a CAGR of 14.37%, to USD 55.75 billion by 2030.

The drug discovery services market is pivotal in healthcare, focusing on providing comprehensive support through various stages of drug research and development, from target identification to lead optimization. This market is essential due to the increasing demand for innovative therapies to treat chronic and life-threatening diseases, coupled with the need for cost-effective solutions. Its applications span across pharmaceutical and biotechnology companies, universities, and research institutions, with end-use encompassing everything from initial drug screening to preclinical and clinical trial assistance. Market growth is fueled by technological advancements like high-throughput screening, bioinformatics, and machine learning, alongside a surge in R&D expenditure and an increase in drug discovery outsourcing. Opportunities lie in expanding AI integration for predictive modeling and personalized medicine, as well as enhancing the drug development process through collaborative partnerships. To seize these opportunities, companies should focus on fostering strategic alliances with research institutions and tech firms, and invest in cutting-edge technologies. However, the market faces challenges such as stringent regulatory requirements, high initial capital investments, and the complexity of drug development processes. These limitations might impede swift growth. Innovations in areas like CRISPR technology for gene editing, real-time data analytics, and improved virtual screening methods present feasible avenues for business growth. As the nature of the market evolves, there is a visible shift towards more collaborative projects and open-source platforms that encourage shared knowledge and resources. Thus, businesses should aim at enhancing their capacity for innovation by adopting flexible operational frameworks that support iterative learning and adaptation. Companies must also remain agile and responsive to regulatory changes and market demands to succeed in this competitive landscape. By focusing on customer needs and technological integration, organizations can better navigate the market's complexities and drive sustainable growth.

KEY MARKET STATISTICS
Base Year [2023] USD 21.77 billion
Estimated Year [2024] USD 24.79 billion
Forecast Year [2030] USD 55.75 billion
CAGR (%) 14.37%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Drug Discovery Services Market

The Drug Discovery Services Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing R&D investments in the pharmaceutical & biopharmaceutical industry
    • Attractive rise in demand for outsourcing analytical testing and clinical trial services
    • Research on rare diseases and orphan drugs
  • Market Restraints
    • Expensive drug discovery and development
  • Market Opportunities
    • Development in the biologics and focus on drug discovery
    • Potential associated with expiry of patents
  • Market Challenges
    • Strict government rules for drug discovery and animal usage

Porter's Five Forces: A Strategic Tool for Navigating the Drug Discovery Services Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Drug Discovery Services Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Drug Discovery Services Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Drug Discovery Services Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Drug Discovery Services Market

A detailed market share analysis in the Drug Discovery Services Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Drug Discovery Services Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Drug Discovery Services Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Drug Discovery Services Market

A strategic analysis of the Drug Discovery Services Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Drug Discovery Services Market, highlighting leading vendors and their innovative profiles. These include Aganitha AI Inc., Agilent Technologies, Inc., Aurigene Discovery Technologies, BellBrook Labs, BioAscent Discovery Ltd., Charles River Laboratories International, Inc., Domainex Ltd., Enzo Life Sciences Inc., Eurofins Scientific SE, Frontage Laboratories, Inc., GenScript Biotech Corporation, Integrated DNA Technologies, Inc., IQVIA Inc, Jubilant Biosys Ltd., Labcorp Drug Development, Merck KGaA, Piramal Pharma Solutions, Proteros biostructures GmbH, Sai Life Sciences Limited, Schrodinger, Inc., Selvita S.A., Shanghai ChemPartner, Shanghai Medicilon, Inc., Symeres, Syngene International Limited, TCG Lifesciences Pvt. Limited, Thermo Fisher Scientific Inc., UCB S.A., Viva Biotech, and Wuxi Apptec.

Market Segmentation & Coverage

This research report categorizes the Drug Discovery Services Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Process, market is studied across Candidate Validation, Hit-to-Lead Identification, Lead Optimization, Target Selection, and Target Validation.
  • Based on Drug Type, market is studied across Biologics and Small Molecules.
  • Based on Service type, market is studied across Biology Services and Chemistry Services.
  • Based on Therapeutic Area, market is studied across Cardiovascular Diseases, Digestive System Diseases, Neurology, and Oncology.
  • Based on End-user, market is studied across Academic Institutes and Pharmaceutical & Biotechnology Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing R&D investments in the pharmaceutical & biopharmaceutical industry
      • 5.1.1.2. Attractive rise in demand for outsourcing analytical testing and clinical trial services
      • 5.1.1.3. Research on rare diseases and orphan drugs
    • 5.1.2. Restraints
      • 5.1.2.1. Expensive drug discovery and development
    • 5.1.3. Opportunities
      • 5.1.3.1. Development in the biologics and focus on drug discovery
      • 5.1.3.2. Potential associated with expiry of patents
    • 5.1.4. Challenges
      • 5.1.4.1. Strict government rules for drug discovery and animal usage
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Drug Discovery Services Market, by Process

  • 6.1. Introduction
  • 6.2. Candidate Validation
  • 6.3. Hit-to-Lead Identification
  • 6.4. Lead Optimization
  • 6.5. Target Selection
  • 6.6. Target Validation

7. Drug Discovery Services Market, by Drug Type

  • 7.1. Introduction
  • 7.2. Biologics
  • 7.3. Small Molecules

8. Drug Discovery Services Market, by Service type

  • 8.1. Introduction
  • 8.2. Biology Services
  • 8.3. Chemistry Services

9. Drug Discovery Services Market, by Therapeutic Area

  • 9.1. Introduction
  • 9.2. Cardiovascular Diseases
  • 9.3. Digestive System Diseases
  • 9.4. Neurology
  • 9.5. Oncology

10. Drug Discovery Services Market, by End-user

  • 10.1. Introduction
  • 10.2. Academic Institutes
  • 10.3. Pharmaceutical & Biotechnology Companies

11. Americas Drug Discovery Services Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Drug Discovery Services Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Drug Discovery Services Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Aganitha AI Inc.
  • 2. Agilent Technologies, Inc.
  • 3. Aurigene Discovery Technologies
  • 4. BellBrook Labs
  • 5. BioAscent Discovery Ltd.
  • 6. Charles River Laboratories International, Inc.
  • 7. Domainex Ltd.
  • 8. Enzo Life Sciences Inc.
  • 9. Eurofins Scientific SE
  • 10. Frontage Laboratories, Inc.
  • 11. GenScript Biotech Corporation
  • 12. Integrated DNA Technologies, Inc.
  • 13. IQVIA Inc
  • 14. Jubilant Biosys Ltd.
  • 15. Labcorp Drug Development
  • 16. Merck KGaA
  • 17. Piramal Pharma Solutions
  • 18. Proteros biostructures GmbH
  • 19. Sai Life Sciences Limited
  • 20. Schrodinger, Inc.
  • 21. Selvita S.A.
  • 22. Shanghai ChemPartner
  • 23. Shanghai Medicilon, Inc.
  • 24. Symeres
  • 25. Syngene International Limited
  • 26. TCG Lifesciences Pvt. Limited
  • 27. Thermo Fisher Scientific Inc.
  • 28. UCB S.A.
  • 29. Viva Biotech
  • 30. Wuxi Apptec

LIST OF FIGURES

  • FIGURE 1. DRUG DISCOVERY SERVICES MARKET RESEARCH PROCESS
  • FIGURE 2. DRUG DISCOVERY SERVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC DRUG DISCOVERY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC DRUG DISCOVERY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. DRUG DISCOVERY SERVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. DRUG DISCOVERY SERVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DRUG DISCOVERY SERVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. DRUG DISCOVERY SERVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY CANDIDATE VALIDATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY HIT-TO-LEAD IDENTIFICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY LEAD OPTIMIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY TARGET SELECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY TARGET VALIDATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY SMALL MOLECULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOLOGY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY CHEMISTRY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY DIGESTIVE SYSTEM DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC DRUG DISCOVERY SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 236. DRUG DISCOVERY SERVICES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 237. DRUG DISCOVERY SERVICES MARKET, FPNV POSITIONING MATRIX, 2023